Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis

Journal of Gastroenterology

Volumn 31, Issue 4, 1996, Pages 552-558

  Chiba, Toshiya ^a   Matsuzaki, Yasushi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Alcohol drinking; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD TRANSFUSION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SEX DIFFERENCE;

EID: 0029802873     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02355056     Document Type: Article

References (32)

1. Parkin DM, Stjernsward J, Muir CS. Estimates of the worldwide frequency of 12 major cancers. Bull WHO 1984;62:162-182.
2. Linsell DA, Hibbinson J. The geographic pathology of liver cell cancer. In: Cameron HM, Linsell DA, Warwick GP (eds). Liver cell cancer. New York: Elsevier, 1976;1-16.
3. Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: Epidemiologic considerations. Hepatology 1982;2(Suppl):21-26.
4. Kew M, Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 1984;4:136-146.
5. Beasley RP, Hwang LY. Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis 1984;4:113-121.
6. Sakuma K, Saitoh N, Kasai M, et al. Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: A prospective study. Hepatology 1988;8:1642-1646.
7. Bruix J, Calvet X, Costa J, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989;II:1004-1006.
8. Columbo M, Kuo G, Choo QL, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989;II:1004-1006.
9. Yu MC, Tong AJ, Cousaget P, et al. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 1990;82:1038-1041.
10. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-675.
11. Nishioka K, Watanabe J, Furuta S, et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991;67:429-433.
12. Tanaka K, Hirohata T, Koga S, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991;51:2842-2847.
13. Resnick RH, Koff R. Hepatitis C-related hepatocellular carcinoma: Prevalence and significance. Arch Int Med 1993;153:1672-1677.
14. Liver Cancer Study Group of Japan. Survey and follow-up study of primary liver cancer in Japan: Report 8 (in Japanese). Acta Hepatol Jap 1988;29:1619-1626.
15. Kalayci C, Johnson PJ, Davies SE, et al. Hepatitis B virus-related hepatocellular carcinoma in the non-cirrhotic liver. J Hepatol 1991;12:54-59.
16. Tanaka T, Miyamoto H, Hino O, et al. Primary hepatocellular carcinoma with hepatitis B virus-DNA integration in a 4-year-old boy. Hum Pathol 1986;17:202-204.
17. Chang MH, Chen PJ, Chen JY, et al. Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood. Hepatology 1991;13:316-320.
18. Ducreux M, Buffer C, Dussaix, et al. Antibody to hepatitis C virus in hepatocellular carcinoma. Lancet 1990;I:300-301.
19. Chiaramonte M, Farinati F, Faginoli S, et al. Antibody to hepatitis C virus in hepatocellular carcinoma. Lancet 1990;I:301-302.
20. Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
21. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:248-275.
22. Kaplan EL, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 1958;53:457-481.
23. Simonetti RG, Camma C, Fiorello F, et al. Hepatocellular carcinoma: A worldwide problem and the major risk factors. Dig Dis Sci 1991;36:962-972.
24. Benvegnù L, Fattovich G, Noventa F, et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. Cancer 1994;74:2442-2448.
25. Tanaka N, Chiba T, Matsuzaki Y, et al. High prevalence of Hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma. Gastroenterol Jpn 1993;28:547-553.
26. Galloway DA, McDougall JK. The oncogenic potential of Herpes simplex viruses: evidence for a "hit and run" mechanism. Nature 1983;302:21-24.
27. Paterlini P, Gerken G, Nakajima E, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990:323:80-85.
28. Kaneko S, Miller RH, Feinstone SM, et al. Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. Proc Natl Acad Sci USA 1989;86:312-316.
29. Liang TJ, Baruch Y, Ben-Porath E, et al. Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology 1991;13:1044-1051.
30. Luo KX, Zhou R, He C, et al. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. J Med Virol 1991:35:55-59.
31. Sheu JC, Huang GT, Shih LN, et al. Hepatitis C and B virus in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology 1992;103:1322-1327.
32. Ruiz J, Sangro B, Cuende JI, et al. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 1992;16:637-641.